Søgeresultater - Kevin Graham

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Monolayer films from poly(lactic acid) PLA/poly(3-hydroxybutyrate-co-hydroxyvalerate) PHBV blends for food packaging applications

    Monolayer films from poly(lactic acid) PLA/poly(3-hydroxybutyrate-co-hydroxyvalerate) PHBV blends for food packaging applications af Hosein Pouriman, Kevin Graham, Krishnan Jayaraman

    Udgivet 2023-10-01

    Four out of twelve different formulations consisting of poly(lactic acid) (PLA), poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV), triethyl citrate (TC), and epoxy-functionalized styrene acrylate (ESA) components were selected based on their superior elongation at break, rheological properties, and...

    Fuld beskrivelse

    Få fuldtekst
    Article

    Føj til favoritter
    Saved in:
  2. 2
    Mechanical, thermal and rheological investigation of poly(lactic acid)(PLA)/poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV) blend within its synergistic elongation effect region

    Mechanical, thermal and rheological investigation of poly(lactic acid)(PLA)/poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV) blend within its synergistic elongation effect region af Hosein Pouriman, Richard Lin, Kevin Graham, Krishnan Jayaraman

    Udgivet 2023-04-01

    A mathematical Design of Experiments (DOE) was structured to consider the interactive effects of poly(lactic acid) (PLA), poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV), triethyl citrate (TC) plasticiser, and epoxy functionalised styrene acrylate (ESA) within the synergistic elongational region o...

    Fuld beskrivelse

    Få fuldtekst
    Article

    Føj til favoritter
    Saved in:
  3. 3
    VERITAS: Harnessing the power of nomenclature in biologic discovery

    VERITAS: Harnessing the power of nomenclature in biologic discovery af Riti Biswas, Ed Belouski, Kevin Graham, Michelle Hortter, Marissa Mock, Christine E. Tinberg, Alan J. Russell

    Udgivet 2023-12-01

    We are entering an era in which therapeutic proteins are assembled using building block-like strategies, with no standardized schema to discuss these formats. Existing nomenclatures, like AbML, sacrifice human readability for precision. Therefore, considering even a dozen such formats, in combinatio...

    Fuld beskrivelse

    Få fuldtekst
    Article

    Føj til favoritter
    Saved in:
  4. 4
    Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies

    Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies af Marissa Mock, Alex W. Jacobitz, Christopher James Langmead, Athena Sudom, Daniel Yoo, Sara C. Humphreys, Mai Alday, Larysa Alekseychyk, Nicolas Angell, Vivian Bi, Hannah Catterall, Chen-Chun Chen, Hui-Ting Chou, Kip P. Conner, Kevin D. Cook, Ana R. Correia, Andrew Dykstra, Sudipa Ghimire-Rijal, Kevin Graham, Peter Grandsard, Joon Huh, John O. Hui, Mani Jain, Victoria Jann, Lei Jia, Sheree Johnstone, Neelam Khanal, Carl Kolvenbach, Linda Narhi, Rupa Padaki, Emma M. Pelegri-O’Day, Wei Qi, Vladimir Razinkov, Austin J. Rice, Richard Smith, Christopher Spahr, Jennitte Stevens, Yax Sun, Veena A. Thomas, Sarah van Driesche, Robert Vernon, Victoria Wagner, Kenneth W. Walker, Yangjie Wei, Dwight Winters, Melissa Yang, Iain D. G. Campuzano

    Udgivet 2023-12-01

    Biologic drug discovery pipelines are designed to deliver protein therapeutics that have exquisite functional potency and selectivity while also manifesting biophysical characteristics suitable for manufacturing, storage, and convenient administration to patients. The ability to use computational me...

    Fuld beskrivelse

    Få fuldtekst
    Article

    Føj til favoritter
    Saved in:

Søgeredskaber: